I just got a tip about ALDX from http://stocktip.xyz. What do you guys think?

With such a small market cap, this is going to double and double again by 2022.

I really wish I found this guy sooner. My market knowledge has increased 10fold and the stock tips cant be beat. (http://webstock.today).

with such a small float it will reach 10 very soon

Wow what an upside potential here!

BTIG Initiates Aldeyra Therapeutics at Buy With $29 Price Target

Interesting premarket activity, time for a new 12 month high? Enjoy everyone, should soon have news.

what is the near term estimate/path for this stock?looks like the market has no interest in this?can some seasoned investors chime in with their views...

very light volume.Under 7 good entry pointgood news next quarter

This is a quiet company, so knowing what is going on requires a simple bit of looking. Aldeyra Receives Study May Proceed Letter from FDA to Initiate Clinical Trial of ADX-629 inCOVID-19 PatientsSeptember 9, 2020LEXINGTON, Mass.--(BUSINESS WIRE)--Sep. 9, 2020-- Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced that it has receiveda Study May Proceed letter from the U.S. Food and Drug Administration (FDA) to begin a Phase 2 clinical trial evaluating ADX-629, a novel orallyavailable reactive aldehyde species (RASP) inhibitor, for the treatment of adult patients hospitalized for COVID-19.“The FDA’s clearance of our Investigational New Drug application for Phase 2 testing in patients with COVID-19 is an important milestone forADX-629, which represents a new paradigm in the treatment of immune-mediated diseases,” stated Todd C. Brady, M.D., Ph.D., President and CEO ofAldeyra. “The COVID-19 clinical trial is part of a broad systemic disease strategy designed to demonstrate ADX-629 proof of concept in seriousinflammatory diseases with critical medical need.”The planned Phase 2 clinical trial is expected to enroll approximately 30 patients with COVID-19. Patients will be enrolled upon hospitalization forCOVID-19 and treated with orally administered ADX-629 or placebo twice-daily for up to 28 days. Key endpoints will include the National Institute ofAllergy and Infectious Diseases COVID-19 scale and levels of cytokines and RASP.Additional proof of concept Phase 2a clinical trials of ADX-629 in psoriasis and atopic asthma are expected to initiate in the fourth quarter of 2020. Thetiming of trial initiations depends, in part, on restrictions related to COVID-19, the availability of clinical research facilities and staffing, the ability torecruit patients, and regulatory feedback.About ADX-629ADX-629 is a novel orally administered RASP inhibitor in Phase 2 clinical development for the treatment of immune-mediated diseases. RASPinhibitors have the potential to represent upstream immunological switches that modulate immune systems from pro-inflammatory states toanti-inflammatory states. ADX-629 is a member of the same chemical class as reproxalap, a RASP inhibitor in Phase 3 clinical trials for dry eyedisease and allergic conjunctivitis, two common ocular inflammatory diseases.

Confusing stock. Currently listed as “overvalued “ on the summary, but ALSO has a 1 year price target of $27.00+. Something has to give. I admit my pure greed overcame my logical self, as a 300%+ appreciation almost had me drooling on my iPad !

https://www.reportdoor.com/these-2-stocks-are-poised-to-surge-by-over-100/

seems to languish in this price range with unconvincing vol..

Bought more shares...Long!!! ALDX, VUZI, GWHP, CKPT...GLTA

Anyone know why the huge drop AH?

Ready to see how average investors and traders are killing it and making thousands a day just from following 1 simple pick a week? Just go to http://Experttrade.uno

Anyone know what these large block trades in at one price in AH might be? There’s been a lot the past few months. Another 180k trade all at $7.14 today. I’ve been trying to figure it out. I have a few ideas of my own but if there’s anyone whose a seasoned veteran that knows for sure. I’d love to hear your thoughts.

Just listened to today's presentation at Cantor. Very interesting where covid is concerned is the difference between ADX 629 anti-inflammatory and ADX 1612 which is antiviral. My conclusion, both drugs are potential blockbusters far and beyond covid.

If you’re a day trader, you should definitely check out http://Experttrade.uno. They send a watchlist covering the top pre-market movers every day before the open. It’s a great way to pick out potential trades for the day.

Going to have a day like the IMMU shareholders are going to have on Monday sometime in 2021 or early 2022. Just saying.